{"id":116,"date":"2025-09-30T13:44:55","date_gmt":"2025-09-30T13:44:55","guid":{"rendered":"https:\/\/www.theisn.org\/frontiers\/?page_id=116"},"modified":"2026-04-20T09:05:22","modified_gmt":"2026-04-20T09:05:22","slug":"program","status":"publish","type":"page","link":"https:\/\/www.theisn.org\/frontiers\/program\/","title":{"rendered":"Provisional program"},"content":{"rendered":"<p>[vc_row][vc_column][vc_column_text]The upcoming ISN Frontiers Meeting in Dalian, China, will focus on novel treatments for kidney disease and feature a focused, single-track agenda exploring the latest innovations in treatment over two days.[\/vc_column_text][vc_tour][vc_tab title=&#8221;Day 1 &#8211; September 5, 2026&#8243; tab_id=&#8221;eeecde79-4372-6&#8243;][vc_column_text]<\/p>\n<table class=\"table\" border=\"1\">\n<tbody><!-- Day Title --><\/p>\n<tr class=\"date-title\" style=\"background-color: #63121d; color: #ffffff;\">\n<th style=\"text-align: center;\" colspan=\"5\">Day 1 &#8211; September 5, 2026<\/th>\n<\/tr>\n<p><!-- Welcome and Opening Session --><\/p>\n<tr>\n<td rowspan=\"4\">\n<h3 class=\"subject-title\"><span class=\"session-title\"><span style=\"color: #63121d;\">Welcome and Opening Session<\/span><\/span><\/h3>\n<\/td>\n<td class=\"time-slot\">17:00 &#8211; 17:10<\/td>\n<td>Opening Address from the ISN Leadership<\/td>\n<td class=\"speaker\">Liz Lightstone<\/td>\n<td class=\"country-flag\" align=\"center\">UK<\/td>\n<\/tr>\n<tr>\n<td class=\"time-slot\">17:10 &#8211; 17:20<\/td>\n<td>CSN Representative\u2019s Welcome Address<\/td>\n<td class=\"speaker\">Guangyan Cai<\/td>\n<td class=\"country-flag\" align=\"center\">China<\/td>\n<\/tr>\n<tr class=\"special-row\">\n<td class=\"time-slot\">17:20 &#8211; 17:30<\/td>\n<td>Welcome and Opening Remarks by ISN Frontiers Co-chairs<\/td>\n<td class=\"speaker\">Masaomi Nangaku \/ Sola Aoun Bahous<\/td>\n<td class=\"country-flag\" align=\"center\">Japan \/ Lebanon<\/td>\n<\/tr>\n<tr>\n<td class=\"time-slot\">17:30 &#8211; 18:30<\/td>\n<td>Building AI Knowledge for Nephrology Practice<br \/>\nWhy Kidney Registries Matter<\/td>\n<td class=\"speaker\">Sola Aoun Bahous<br \/>\nFergus Caskey<\/td>\n<td class=\"country-flag\" align=\"center\">Lebanon<br \/>\nUnited Kingdom<\/td>\n<\/tr>\n<p><!-- Reception --><\/p>\n<tr class=\"greybg\" style=\"background-color: #911d22; color: #fff;\">\n<td><strong>Welcome &amp; Networking Reception<\/strong><\/td>\n<td class=\"time-slot\">18:30 &#8211; 19:30<\/td>\n<td>Welcome &amp; Networking Reception (60 minutes)<\/td>\n<td class=\"speaker\"><\/td>\n<td class=\"speaker\"><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>[\/vc_column_text][\/vc_tab][vc_tab title=&#8221;Day 2 &#8211; September 6, 2026&#8243; tab_id=&#8221;1759236180933-1-9&#8243;][vc_column_text]<\/p>\n<table class=\"table\" border=\"1\">\n<tbody><!-- Day Title --><\/p>\n<tr class=\"date-title\" style=\"background-color: #63121d; color: #ffffff;\">\n<th style=\"text-align: center;\" colspan=\"5\">Day 2 &#8211; September 6, 2026<\/th>\n<\/tr>\n<p><!-- Session 2: Keynote --><\/p>\n<tr class=\"special-row-\">\n<td class=\"subject-title\">\n<h3><span style=\"color: #63121d;\">Session 2: Keynote<\/span><\/h3>\n<\/td>\n<td class=\"time-slot\">08:30 &#8211; 09:10<\/td>\n<td>MRAs for Cardio-Kidney-Metabolic Health<\/td>\n<td class=\"speaker\"><\/td>\n<td class=\"country-flag\" align=\"center\"><\/td>\n<\/tr>\n<p><!-- Session 3 --><\/p>\n<tr>\n<td class=\"subject-title\" rowspan=\"2\">\n<h3><span class=\"session-title\"><span style=\"color: #63121d;\">Session 3:<\/span><\/span><\/h3>\n<p>Cardio-kidney-metabolic 1 &#8211; Research and clinical trials<\/p>\n<p><em>Integrating CKM Research and Clinical Trials Into Patient Care<\/em><\/td>\n<td class=\"time-slot\">09:15 &#8211; 09:40<\/td>\n<td>Linking MRA to Cardio-Kidney-Metabolic Care<\/td>\n<td class=\"speaker\"><\/td>\n<td class=\"country-flag\" align=\"center\"><\/td>\n<\/tr>\n<tr>\n<td class=\"time-slot\">09:40 &#8211; 10:05<\/td>\n<td>Intensive Blood Pressure Control for Better Outcomes in Diabetic CKD<\/td>\n<td class=\"speaker\"><\/td>\n<td class=\"country-flag\" align=\"center\"><\/td>\n<\/tr>\n<p><!-- Coffee Break --><\/p>\n<tr class=\"greybg\" style=\"background-color: #edeef9;\">\n<td>Coffee Break<\/td>\n<td class=\"time-slot\">10:05 &#8211; 10:30<\/td>\n<td>Coffee Break and Poster Viewing (25 minutes)<\/td>\n<td class=\"speaker\"><\/td>\n<td class=\"speaker\"><\/td>\n<\/tr>\n<p><!-- Session 4 --><\/p>\n<tr>\n<td class=\"subject-title\" rowspan=\"3\">\n<h3><span class=\"session-title\"><span style=\"color: #63121d;\">Session 4:<\/span><\/span><\/h3>\n<p>Rare Kidney Diseases 1 &#8211; Implementation<\/p>\n<p><em>Rare Kidney Diseases: From Mechanisms to Implementation<\/em><\/td>\n<td class=\"time-slot\">10:30 &#8211; 10:55<\/td>\n<td>Endothelin A Receptor Antagonists in IgA Nephropathy<\/td>\n<td class=\"speaker\">Meg Jardine<\/td>\n<td class=\"country-flag\" align=\"center\">Australia<\/td>\n<\/tr>\n<tr>\n<td class=\"time-slot\">10:55 &#8211; 11:20<\/td>\n<td>How Complement Pathways Drive IgA Nephropathy<\/td>\n<td class=\"speaker\"><\/td>\n<td class=\"country-flag\" align=\"center\"><\/td>\n<\/tr>\n<tr>\n<td class=\"time-slot\">11:20 &#8211; 11:45<\/td>\n<td>CRISPR Gene Editing for APOL1-Associated Kidney Disease<\/td>\n<td class=\"speaker\"><\/td>\n<td class=\"country-flag\" align=\"center\"><\/td>\n<\/tr>\n<p><!-- Lunch Break --><\/p>\n<tr class=\"greybg\" style=\"background-color: #edeef9;\">\n<td>Lunch Break<\/td>\n<td class=\"time-slot\">11:45 &#8211; 13:15<\/td>\n<td>Lunch Break \/ Lunch Symposium (90 minutes)<\/td>\n<td class=\"speaker\"><\/td>\n<td class=\"speaker\"><\/td>\n<\/tr>\n<p><!-- Session 5 --><\/p>\n<tr>\n<td class=\"subject-title\" rowspan=\"4\">\n<h3><span class=\"session-title\"><span style=\"color: #63121d;\">Session 5:<\/span><\/span><\/h3>\n<p>AKI<\/p>\n<p><em>Innovations in AKI: From Lab to Clinic<\/em><\/td>\n<td class=\"time-slot\">13:15 &#8211; 13:40<\/td>\n<td>Linking Molecular Pathways to AKI Outcomes<\/td>\n<td class=\"speaker\">Motoko Yanagita<\/td>\n<td class=\"country-flag\" align=\"center\">Japan<\/td>\n<\/tr>\n<tr>\n<td class=\"time-slot\">13:40 &#8211; 14:05<\/td>\n<td>Can AI Detect AKI Early?<\/td>\n<td class=\"speaker\"><\/td>\n<td class=\"country-flag\" align=\"center\"><\/td>\n<\/tr>\n<tr>\n<td class=\"time-slot\">14:05 &#8211; 14:30<\/td>\n<td>Protecting Kidneys in Cardiac Surgery: The RIPC Approach<\/td>\n<td class=\"speaker\">Xiao-Qiang Ding<\/td>\n<td class=\"country-flag\" align=\"center\">China<\/td>\n<\/tr>\n<tr>\n<td class=\"time-slot\">14:30 &#8211; 14:55<\/td>\n<td>Stem Cell Therapy for AKI: From Bench to Bedside<\/td>\n<td class=\"speaker\">Guangyan Cai<\/td>\n<td class=\"country-flag\" align=\"center\">China<\/td>\n<\/tr>\n<p><!-- Coffee Break --><\/p>\n<tr class=\"greybg\" style=\"background-color: #edeef9;\">\n<td>Coffee Break<\/td>\n<td class=\"time-slot\">14:55 &#8211; 15:25<\/td>\n<td>Coffee Break and Poster Viewing (30 minutes)<\/td>\n<td class=\"speaker\"><\/td>\n<td class=\"speaker\"><\/td>\n<\/tr>\n<p><!-- Session 6 --><\/p>\n<tr>\n<td class=\"subject-title\" rowspan=\"4\">\n<h3><span class=\"session-title\"><span style=\"color: #63121d;\">Session 6:<\/span><\/span><\/h3>\n<p>Cardio-kidney-metabolic 2 &#8211; Implementation<\/p>\n<p><em>Implementing Cardio-Kidney-Metabolic Care: From Mechanisms to Global Burden<\/em><\/td>\n<td class=\"time-slot\">15:25 &#8211; 15:50<\/td>\n<td>Molecular Mechanisms of Cardio-Kidney-Metabolic Syndrome<\/td>\n<td class=\"speaker\"><\/td>\n<td class=\"country-flag\" align=\"center\"><\/td>\n<\/tr>\n<tr>\n<td class=\"time-slot\">15:50 &#8211; 16:15<\/td>\n<td>Burden of Cardio-Kidney-Metabolic Syndrome in Asia<\/td>\n<td class=\"speaker\">Sunita Bavanandan<\/td>\n<td class=\"country-flag\" align=\"center\">Malaysia<\/td>\n<\/tr>\n<tr>\n<td class=\"time-slot\">16:15 &#8211; 16:40<\/td>\n<td>Cardio-Kidney-Metabolic Syndrome: An Integrated Approach to the Global Health Burden<\/td>\n<td class=\"speaker\">Pringgodigdo Nugroho<\/td>\n<td class=\"country-flag\" align=\"center\">Indonesia<\/td>\n<\/tr>\n<tr>\n<td class=\"time-slot\">16:40 &#8211; 17:05<\/td>\n<td>TBC<\/td>\n<td class=\"speaker\"><span data-olk-copy-source=\"MessageBody\">Adeera Levin<\/span><\/td>\n<td class=\"country-flag\" align=\"center\">Canada<\/td>\n<\/tr>\n<p><!-- Industry Symposium --><\/p>\n<tr class=\"special-row\" style=\"background-color: #f29556;\">\n<td class=\"subject-title\"><strong>Industry Symposium<\/strong><\/td>\n<td class=\"time-slot\">17:05 &#8211; 18:05<\/td>\n<td>Industry Symposium (60 minutes)<\/td>\n<td class=\"speaker\"><\/td>\n<td class=\"speaker\"><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>[\/vc_column_text][\/vc_tab][vc_tab title=&#8221;Day 3 &#8211; September 7, 2026&#8243; tab_id=&#8221;1759236181786-2-4&#8243;][vc_column_text]<\/p>\n<table class=\"table\" border=\"1\">\n<tbody><!-- Day Title --><\/p>\n<tr class=\"date-title\" style=\"background-color: #63121d; color: #ffffff;\">\n<th style=\"text-align: center;\" colspan=\"5\">Day 3 &#8211; September 7, 2026<\/th>\n<\/tr>\n<p><!-- Session 7: Keynote --><\/p>\n<tr class=\"special-row\">\n<td class=\"subject-title\">\n<h3><span class=\"session-title\"><span style=\"color: #63121d;\">Session 7: Keynote<\/span><\/span><\/h3>\n<\/td>\n<td class=\"time-slot\">08:30 &#8211; 09:10<\/td>\n<td>Telemedicine and AI for Smarter Nephrology Practice<\/td>\n<td class=\"speaker\">Masaomi Nangaku<\/td>\n<td class=\"country-flag\" align=\"center\">Japan<\/td>\n<\/tr>\n<p><!-- Session 8: Panel --><\/p>\n<tr>\n<td class=\"subject-title\" rowspan=\"4\">\n<h3><span class=\"session-title\"><span style=\"color: #63121d;\">Session 8:<\/span><\/span><\/h3>\n<p>Innovations &amp; AI in Nephrology &#8211; Panel<br \/>\n<em>Application of Artificial Intelligence and Digital Transformation in Kidney Care<\/em><\/td>\n<td class=\"time-slot\" rowspan=\"4\">09:15 &#8211; 10:15<\/td>\n<td>AI in Transplantation Pathology<\/td>\n<td class=\"speaker\">Alton B Farris<\/td>\n<td class=\"country-flag\" align=\"center\">USA<\/td>\n<\/tr>\n<tr>\n<td>Unveiling Kidney Disease Through Body Gas Sensing Techniques<\/td>\n<td class=\"speaker\">Yosuke Hirakawa<\/td>\n<td class=\"country-flag\" align=\"center\">Japan<\/td>\n<\/tr>\n<tr>\n<td>Multi-Stain Deep Learning Model to Predict Treatment Response in Lupus Nephritis<\/td>\n<td class=\"speaker\">Wei Chen<\/td>\n<td class=\"country-flag\" align=\"center\">China<\/td>\n<\/tr>\n<tr>\n<td>AI and Kidney Disease<\/td>\n<td class=\"speaker\">Lu-Xia Zhang<\/td>\n<td class=\"country-flag\" align=\"center\">China<\/td>\n<\/tr>\n<p><!-- Coffee Break --><\/p>\n<tr class=\"greybg\" style=\"background-color: #edeef9;\">\n<td>Coffee Break<\/td>\n<td class=\"time-slot\">10:15 &#8211; 10:45<\/td>\n<td>Coffee Break and Poster Viewing (30 minutes)<\/td>\n<td class=\"speaker\"><\/td>\n<td class=\"speaker\"><\/td>\n<\/tr>\n<p><!-- Session 9 --><\/p>\n<tr>\n<td class=\"subject-title\" rowspan=\"5\">\n<h3><span class=\"session-title\"><span style=\"color: #63121d;\">Session 9:<\/span><\/span><\/h3>\n<p>Blood Purification<br \/>\n<em>Innovations in Blood Purification for Kidney Disease<\/em><\/td>\n<td class=\"time-slot\">10:45 &#8211; 11:10<\/td>\n<td>Glycation End Products and Kidney Disease<\/td>\n<td class=\"speaker\">Kornchanok Vareesangthip<\/td>\n<td class=\"country-flag\" align=\"center\">Thailand<\/td>\n<\/tr>\n<tr>\n<td class=\"time-slot\">11:10 &#8211; 11:35<\/td>\n<td>Peritoneal Dialysis: Advances and Challenges<\/td>\n<td class=\"speaker\">Winston Fung<\/td>\n<td class=\"country-flag\" align=\"center\">Hong Kong (China)<\/td>\n<\/tr>\n<tr>\n<td class=\"time-slot\">11:35 &#8211; 12:00<\/td>\n<td>HIF Inhibitors: Transforming Anaemia Care<\/td>\n<td class=\"speaker\">Ping Li<\/td>\n<td class=\"country-flag\" align=\"center\">China<\/td>\n<\/tr>\n<tr>\n<td class=\"time-slot\">12:00 &#8211; 12:25<\/td>\n<td>Novel Blood Purification Approaches in Kidney Care<\/td>\n<td class=\"speaker\">Hong-Li Lin<\/td>\n<td class=\"country-flag\" align=\"center\">China<\/td>\n<\/tr>\n<tr>\n<td class=\"time-slot\">12:25 &#8211; 12:40<\/td>\n<td>Oral Presentation from abstract submission<\/td>\n<td class=\"speaker\"><em>Abstract<\/em><\/td>\n<td class=\"country-flag\" align=\"center\"><\/td>\n<\/tr>\n<p><!-- Lunch Break --><\/p>\n<tr class=\"greybg\" style=\"background-color: #edeef9;\">\n<td>Lunch Break<\/td>\n<td class=\"time-slot\">12:40 &#8211; 14:10<\/td>\n<td>Lunch Break \/ Lunch Symposium (90 minutes)<\/td>\n<td class=\"speaker\"><\/td>\n<td class=\"speaker\"><\/td>\n<\/tr>\n<p><!-- Session 10 --><\/p>\n<tr>\n<td class=\"subject-title\" rowspan=\"5\">\n<h3><span class=\"session-title\"><span style=\"color: #63121d;\">Session 10:<\/span><\/span><\/h3>\n<p>Rare Kidney Diseases &#8211; Research and Clinical Trials<br \/>\n<em>Research and Trials Driving Advances in Rare Kidney Diseases<\/em><\/td>\n<td class=\"time-slot\">14:10 &#8211; 14:35<\/td>\n<td>Genetic Diagnosis of Rare Kidney Diseases<\/td>\n<td class=\"speaker\"><\/td>\n<td class=\"country-flag\" align=\"center\"><\/td>\n<\/tr>\n<tr>\n<td class=\"time-slot\">14:35 &#8211; 15:00<\/td>\n<td>Rare Kidney Diseases in China: Challenges and Progress<\/td>\n<td class=\"speaker\"><\/td>\n<td class=\"country-flag\" align=\"center\"><\/td>\n<\/tr>\n<tr>\n<td class=\"time-slot\">15:00 &#8211; 15:25<\/td>\n<td>Managing Kidney Involvement in Lupus<\/td>\n<td class=\"speaker\"><\/td>\n<td class=\"country-flag\" align=\"center\"><\/td>\n<\/tr>\n<tr>\n<td class=\"time-slot\">15:25 &#8211; 15:50<\/td>\n<td>Improving Outcomes for Children With Rare Kidney Disease<\/td>\n<td class=\"speaker\"><\/td>\n<td class=\"country-flag\" align=\"center\"><\/td>\n<\/tr>\n<tr>\n<td class=\"time-slot\">15:50 &#8211; 16:05<\/td>\n<td>Oral Presentation from abstract submission<\/td>\n<td class=\"speaker\"><em>Abstract<\/em><\/td>\n<td class=\"country-flag\" align=\"center\">TBC<\/td>\n<\/tr>\n<p><!-- Coffee Break --><\/p>\n<tr class=\"greybg\" style=\"background-color: #edeef9;\">\n<td>Coffee Break<\/td>\n<td class=\"time-slot\">16:05 &#8211; 16:35<\/td>\n<td>Coffee Break and Poster Viewing (30 minutes)<\/td>\n<td class=\"speaker\"><\/td>\n<td class=\"speaker\"><\/td>\n<\/tr>\n<p><!-- Session 11 --><\/p>\n<tr>\n<td class=\"subject-title\" rowspan=\"4\">\n<h3><span class=\"session-title\"><span style=\"color: #63121d;\">Session 11:<\/span><\/span><\/h3>\n<p>Cardio-kidney-metabolic 3 &amp; Closing Remarks<br \/>\n<em>Advances in CKM Care and Closing Remarks<\/em><\/td>\n<td class=\"time-slot\">16:35 &#8211; 17:00<\/td>\n<td>Integrating GLP-1RA Into Cardio-Kidney-Metabolic Management<\/td>\n<td class=\"speaker\"><span data-olk-copy-source=\"MessageBody\">Sydney Tang<\/span><\/td>\n<td class=\"country-flag\" align=\"center\"><span data-olk-copy-source=\"MessageBody\">Hong Kong, China<\/span><\/td>\n<\/tr>\n<tr>\n<td class=\"time-slot\">17:00 &#8211; 17:25<\/td>\n<td>SGLT2i for CKD: Expanding Benefits Beyond Diabetes<\/td>\n<td class=\"speaker\">Xiao-Xi Zeng<\/td>\n<td class=\"country-flag\" align=\"center\">China<\/td>\n<\/tr>\n<tr>\n<td class=\"time-slot\">17:25 &#8211; 17:40<\/td>\n<td>Oral Presentation from abstract submission<\/td>\n<td class=\"speaker\"><em>Abstract<\/em><\/td>\n<td class=\"country-flag\" align=\"center\">TBC<\/td>\n<\/tr>\n<tr>\n<td class=\"time-slot\">17:40 &#8211; 18:00<\/td>\n<td>Reflections and Closing Remarks From the ISN Frontiers Co-chairs<\/td>\n<td class=\"speaker\">Guangyan Cai, Masaomi Nangaku, Sola Aoun Bahous<\/td>\n<td class=\"country-flag\" align=\"center\">China \/ Japan \/ Lebanon<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>[\/vc_column_text][\/vc_tab][\/vc_tour][\/vc_column][\/vc_row]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>[vc_row][vc_column][vc_column_text]The upcoming ISN Frontiers Meeting in Dalian, China, will focus on novel treatments for kidney disease and feature a focused, single-track agenda exploring the latest innovations in treatment over two days.[\/vc_column_text][vc_tour][vc_tab title=&#8221;Day 1 &#8211; September 5, 2026&#8243; tab_id=&#8221;eeecde79-4372-6&#8243;][vc_column_text] Day 1 &#8211; September 5, 2026 Welcome and Opening Session 17:00 &#8211; 17:10 Opening Address from the [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-116","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v14.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Provisional program - ISN Frontiers Meetings<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.theisn.org\/frontiers\/program\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Provisional program - ISN Frontiers Meetings\" \/>\n<meta property=\"og:description\" content=\"[vc_row][vc_column][vc_column_text]The upcoming ISN Frontiers Meeting in Dalian, China, will focus on novel treatments for kidney disease and feature a focused, single-track agenda exploring the latest innovations in treatment over two days.[\/vc_column_text][vc_tour][vc_tab title=&#8221;Day 1 &#8211; September 5, 2026&#8243; tab_id=&#8221;eeecde79-4372-6&#8243;][vc_column_text] Day 1 &#8211; September 5, 2026 Welcome and Opening Session 17:00 &#8211; 17:10 Opening Address from the [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.theisn.org\/frontiers\/program\/\" \/>\n<meta property=\"og:site_name\" content=\"ISN Frontiers Meetings\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-20T09:05:22+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.theisn.org\/frontiers\/#website\",\"url\":\"https:\/\/www.theisn.org\/frontiers\/\",\"name\":\"ISN Frontiers Meetings\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":\"https:\/\/www.theisn.org\/frontiers\/?s={search_term_string}\",\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.theisn.org\/frontiers\/program\/#webpage\",\"url\":\"https:\/\/www.theisn.org\/frontiers\/program\/\",\"name\":\"Provisional program - ISN Frontiers Meetings\",\"isPartOf\":{\"@id\":\"https:\/\/www.theisn.org\/frontiers\/#website\"},\"datePublished\":\"2025-09-30T13:44:55+00:00\",\"dateModified\":\"2026-04-20T09:05:22+00:00\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.theisn.org\/frontiers\/program\/\"]}]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","_links":{"self":[{"href":"https:\/\/www.theisn.org\/frontiers\/wp-json\/wp\/v2\/pages\/116"}],"collection":[{"href":"https:\/\/www.theisn.org\/frontiers\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.theisn.org\/frontiers\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.theisn.org\/frontiers\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.theisn.org\/frontiers\/wp-json\/wp\/v2\/comments?post=116"}],"version-history":[{"count":6,"href":"https:\/\/www.theisn.org\/frontiers\/wp-json\/wp\/v2\/pages\/116\/revisions"}],"predecessor-version":[{"id":445,"href":"https:\/\/www.theisn.org\/frontiers\/wp-json\/wp\/v2\/pages\/116\/revisions\/445"}],"wp:attachment":[{"href":"https:\/\/www.theisn.org\/frontiers\/wp-json\/wp\/v2\/media?parent=116"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}